<DOC>
	<DOC>NCT00923572</DOC>
	<brief_summary>The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.</brief_summary>
	<brief_title>Yasmin Post Marketing Surveillance</brief_title>
	<detailed_description />
	<mesh_term>Drospirenone and ethinyl estradiol combination</mesh_term>
	<criteria>Women who need oral contraceptive Patient who belongs to contraindication listed on the product label.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Oral contraceptive</keyword>
</DOC>